Cargando…
免疫检查点抑制剂相关肾脏不良反应的临床诊治建议
Immune checkpoint inhibitors (ICIs) have been used more and more Increasingly in clinical oncology treatment, which has significantly improved the prognosis of cancer patients. Over-activation of T cells and related signaling pathways may cause immune-related adverse effects. Renal immune side-effec...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817426/ https://www.ncbi.nlm.nih.gov/pubmed/31650947 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.07 |